Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2024

Stockholders' Equity [Abstract]

Schedule of Grant Date Fair Value of Options Granted

The Company determined the grant date fair value of options granted for the three months ended March 31, 2024, using the Black Scholes Method, as applicable, with the following assumptions:

Expected volatility	123%
Expected term	5 years
Risk free rate	3.80% – 4.03%
Dividend rate	0.00%

Schedule of Activity Related to Stock Options

Activity related to stock options for the three months ended March 31, 2024 (unaudited), is summarized as follows:

				Weighted		Weighted
				Average		Average		Aggregate
	Number of			Exercise		Contractual		Intrinsic
	Shares			Price		Term (Yrs.)		Value
Outstanding at December 31, 2023		1,796,743		$	25.20		6.5	$	3,630,733
Granted		100,000		$	9.38		10.0	$	-
Exercised		-		$	-		-	$	-
Forfeited/cancelled		(15,772	)	$	13.35		4.3	$	-
Outstanding as of March 31, 2024		1,880,971		$	24.23		6.4	$	2,163,663
Exercisable as of March 31, 2024		1,158,568		$	30.57		5.0	$	1,085,676

Schedule of Stock Option Information

The following table summarizes stock option information as of March 31, 2024 (unaudited):

			Weighted
			Average
			Contractual
Exercise Price	Outstanding		Term (Yrs.)		Exercisable
$2.64 – $5.00		354,379		8.8		171,103
$5.01 – $10.00		661,189		9.1		224,949
$10.01 – $15.00		43,703		2.7		43,703
$15.01 – $20.00		252,084		1.5		252,084
$20.01 – $121.28		569,616		4.1		466,729
		1,880,971		6.1		1,158,568